» Articles » PMID: 28694740

Review of Hepatocellular Carcinoma: Epidemiology, Etiology, and Carcinogenesis

Overview
Journal J Carcinog
Publisher Biomed Central
Date 2017 Jul 12
PMID 28694740
Citations 372
Authors
Affiliations
Soon will be listed here.
Abstract

Since the 1970s, the epidemic of hepatocellular carcinoma (HCC) has spread beyond the Eastern Asian predominance and has been increasing in Northern hemisphere, especially in the United States (US) and Western Europe. It occurs more commonly in males in the fourth and fifth decades of life. Among all cancers, HCC is one of the fastest growing causes of death in the US and poses a significant economic burden on healthcare. Chronic liver disease due to hepatitis B virus or hepatitis C virus and alcohol accounts for the majority of HCC cases. Incidence of nonalcoholic fatty liver disease has been on the risem and it has also been associated with the development of HCC. Its pathogenesis varies based on the underlying etiological factor although majority of cases develop in the setting of background cirrhosis. Carcinogenesis of HCC includes angiogenesis, chronic inflammation, and tumor macroenvironment and microenvironment. There is a significant role of both intrinsic genetic risk factors and extrinsic influences such as alcohol or viral infections that lead to the development of HCC. Understanding its etiopathogenesis helps select appropriate diagnostic tests and treatments.

Citing Articles

Expression of miR-15b-5p and toll-like receptor4 as potential novel diagnostic biomarkers for hepatitis C virus-induced hepatocellular carcinoma.

Mohamed A, Nagah Amer N, Osama N, Hafez W, Abdelrahman Ali A, Shaheen M Noncoding RNA Res. 2025; 10():262-268.

PMID: 39844891 PMC: 11751402. DOI: 10.1016/j.ncrna.2024.12.003.


DPP4, a potential tumor biomarker, and tumor therapeutic target: review.

Sun L, Ma Y, Geng C, Gao X, Li X, Ru Q Mol Biol Rep. 2025; 52(1):126.

PMID: 39821530 DOI: 10.1007/s11033-025-10235-6.


Regulatory role of lnc-MAP3K13-3:1 on miR-6894-3p and SHROOM2 in modulating cellular dynamics in hepatocellular carcinoma.

Chen K, Zhu M, Hu Q, Huang H, Chen K, Shuai X BMC Cancer. 2025; 25(1):83.

PMID: 39810131 PMC: 11731390. DOI: 10.1186/s12885-024-13263-w.


The tumor distance to the main hepatic vessels is a predictor of recurrence-free survival and overall survival in hepatocellular cancer.

Abdelhadi S, Rink J, Froelich M, Sandra-Petrescu F, El-Ahmar M, Oweira H Langenbecks Arch Surg. 2025; 410(1):31.

PMID: 39786609 PMC: 11717872. DOI: 10.1007/s00423-024-03565-9.


Update on Resection Strategies for Hepatocellular Carcinoma: A Narrative Review.

Lee J, Choi H, Kim J, Lee T, Yoon Y Cancers (Basel). 2024; 16(23).

PMID: 39682279 PMC: 11640626. DOI: 10.3390/cancers16234093.


References
1.
Erhardt A, Blondin D, Hauck K, Sagir A, Kohnle T, Heintges T . Response to interferon alfa is hepatitis B virus genotype dependent: genotype A is more sensitive to interferon than genotype D. Gut. 2005; 54(7):1009-13. PMC: 1774609. DOI: 10.1136/gut.2004.060327. View

2.
Njei B, Rotman Y, Ditah I, Lim J . Emerging trends in hepatocellular carcinoma incidence and mortality. Hepatology. 2014; 61(1):191-9. PMC: 4823645. DOI: 10.1002/hep.27388. View

3.
Lewin S, Walters T, Locarnini S . Hepatitis B treatment: rational combination chemotherapy based on viral kinetic and animal model studies. Antiviral Res. 2002; 55(3):381-96. DOI: 10.1016/s0166-3542(02)00071-2. View

4.
Hino O, Kajino K, Umeda T, Arakawa Y . Understanding the hypercarcinogenic state in chronic hepatitis: a clue to the prevention of human hepatocellular carcinoma. J Gastroenterol. 2002; 37(11):883-7. DOI: 10.1007/s005350200149. View

5.
Tang H, Delgermaa L, Huang F, Oishi N, Liu L, He F . The transcriptional transactivation function of HBx protein is important for its augmentation role in hepatitis B virus replication. J Virol. 2005; 79(9):5548-56. PMC: 1082733. DOI: 10.1128/JVI.79.9.5548-5556.2005. View